319 related articles for article (PubMed ID: 28205547)
1. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.
Hajarnis S; Lakhia R; Yheskel M; Williams D; Sorourian M; Liu X; Aboudehen K; Zhang S; Kersjes K; Galasso R; Li J; Kaimal V; Lockton S; Davis S; Flaten A; Johnson JA; Holland WL; Kusminski CM; Scherer PE; Harris PC; Trudel M; Wallace DP; Igarashi P; Lee EC; Androsavich JR; Patel V
Nat Commun; 2017 Feb; 8():14395. PubMed ID: 28205547
[TBL] [Abstract][Full Text] [Related]
2. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
Lakhia R; Yheskel M; Flaten A; Ramalingam H; Aboudehen K; Ferrè S; Biggers L; Mishra A; Chaney C; Wallace DP; Carroll T; Igarashi P; Patel V
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32182218
[TBL] [Abstract][Full Text] [Related]
3. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.
Lakhia R; Hajarnis S; Williams D; Aboudehen K; Yheskel M; Xing C; Hatley ME; Torres VE; Wallace DP; Patel V
J Am Soc Nephrol; 2016 Aug; 27(8):2319-30. PubMed ID: 26677864
[TBL] [Abstract][Full Text] [Related]
5. Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.
Yheskel M; Lakhia R; Cobo-Stark P; Flaten A; Patel V
Sci Rep; 2019 Feb; 9(1):1920. PubMed ID: 30760828
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic microRNAs in polycystic kidney disease.
Yheskel M; Patel V
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):282-289. PubMed ID: 28399020
[TBL] [Abstract][Full Text] [Related]
7. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
8. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
10. The role of PPARα in autosomal dominant polycystic kidney disease.
Lakhia R
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):432-438. PubMed ID: 32427692
[TBL] [Abstract][Full Text] [Related]
11. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.
Kim DY; Woo YM; Lee S; Oh S; Shin Y; Shin JO; Park EY; Ko JY; Lee EJ; Bok J; Yoo KH; Park JH
FASEB J; 2019 Feb; 33(2):2870-2884. PubMed ID: 30332302
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.
Lee EJ; Park EY; Mun H; Chang E; Ko JY; Kim DY; Park JH
FASEB J; 2015 Aug; 29(8):3506-14. PubMed ID: 25934702
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C.
Sun L; Zhu J; Wu M; Sun H; Zhou C; Fu L; Xu C; Mei C
Med Sci Monit; 2015 Jan; 21():195-200. PubMed ID: 25588980
[TBL] [Abstract][Full Text] [Related]
14. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
[TBL] [Abstract][Full Text] [Related]
15. Macrophages promote polycystic kidney disease progression.
Swenson-Fields KI; Vivian CJ; Salah SM; Peda JD; Davis BM; van Rooijen N; Wallace DP; Fields TA
Kidney Int; 2013 May; 83(5):855-64. PubMed ID: 23423256
[TBL] [Abstract][Full Text] [Related]
16. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.
Leonhard WN; Zandbergen M; Veraar K; van den Berg S; van der Weerd L; Breuning M; de Heer E; Peters DJ
J Am Soc Nephrol; 2015 Jun; 26(6):1322-33. PubMed ID: 25361818
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.
Zhou X; Fan LX; Peters DJ; Trudel M; Bradner JE; Li X
Hum Mol Genet; 2015 Jul; 24(14):3982-93. PubMed ID: 25877301
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
Ding H; Li LX; Harris PC; Yang J; Li X
Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
[TBL] [Abstract][Full Text] [Related]
19. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
[TBL] [Abstract][Full Text] [Related]
20. Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models.
Woo YM; Kim DY; Koo NJ; Kim YM; Lee S; Ko JY; Shin Y; Kim BH; Mun H; Choi S; Lee EJ; Shin JO; Park EY; Bok J; Park JH
Sci Rep; 2017 Oct; 7(1):14151. PubMed ID: 29074972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
